INSP
Inspire Medical Systems Inc
NYSE · Health Care
$65.70
+0.10 (+0.15%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 763.73M | 505.95M | 843.64M | 839.97M | 903.31M |
| Net Income | 50.90M | 30.35M | 117.12M | 115.26M | 130.49M |
| EPS | — | — | — | — | — |
| Profit Margin | 6.7% | 6.3% | 13.9% | 13.7% | 14.5% |
| Rev Growth | +51.0% | +51.0% | -1.8% | +7.1% | +16.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 698.60M | 763.45M | 733.86M |
| Total Equity | — | — | 673.48M | 726.74M | 653.19M |
| D/E Ratio | — | — | 1.04 | 1.05 | 1.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 40.60M | 25.55M | 171.32M | 164.81M | 191.90M |
| Free Cash Flow | — | — | 69.07M | 91.81M | 92.39M |